Difference between revisions of "Proton pump inhibitor effect"

From Libre Pathology
Jump to navigation Jump to search
Line 7: Line 7:
*Due to intake of a proton pump inhibitor (PPI).
*Due to intake of a proton pump inhibitor (PPI).
**Used to treat [[gastroesophageal reflux disease]].
**Used to treat [[gastroesophageal reflux disease]].
Some proton pump inhibitors:
*Omeprazole (LOSEC).
*Dexlansoprazole (DEXILANT).
*Lansoprazole (PREVACID).
*Esomeprazole (NEXIUM).
*Pantoprazole (PANTOLOC).
*Rabeprazole (PARIET).


==Microscopic==
==Microscopic==

Revision as of 21:13, 20 January 2014

Stomach with PPI effect. H&E stain.

Proton pump inhibitor effect, abbreviated PPI effect, is a change seen in the parietal cells of the stomach due to a drug in the proton pump inhibitor class.

Formally, it is stomach with proton pump inhibitor effect.

General

Some proton pump inhibitors:

  • Omeprazole (LOSEC).
  • Dexlansoprazole (DEXILANT).
  • Lansoprazole (PREVACID).
  • Esomeprazole (NEXIUM).
  • Pantoprazole (PANTOLOC).
  • Rabeprazole (PARIET).

Microscopic

Features:[1]

  • Parietal cell enlargement - key feature.
    • Parietal cells typically bulge into the lumen.

Images

www:

Sign out

  • Usually not reported.

See also

References

  1. Driman, DK.; Wright, C.; Tougas, G.; Riddell, RH. (Oct 1996). "Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.". Dig Dis Sci 41 (10): 2039-47. PMID 8888719.